1. Home
  2. CDNA vs EVO Comparison

CDNA vs EVO Comparison

Compare CDNA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.00

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
EVO
Founded
1998
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
934.1M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
EVO
Price
$21.60
$3.00
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$28.00
$7.00
AVG Volume (30 Days)
652.5K
85.0K
Earning Date
04-28-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
$1.37
Revenue Next Year
$11.31
$10.05
P/E Ratio
$429.80
N/A
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$2.31
52 Week High
$23.24
$4.48

Technical Indicators

Market Signals
Indicator
CDNA
EVO
Relative Strength Index (RSI) 59.06 53.04
Support Level $15.80 $2.88
Resistance Level $22.89 $3.36
Average True Range (ATR) 1.00 0.09
MACD -0.06 -0.01
Stochastic Oscillator 76.54 54.34

Price Performance

Historical Comparison
CDNA
EVO

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: